Loading…
GeneDx Holdings Corp. is projected to rise to $67.75 by 2027, a +41% move from its current price of $48.21. WGS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $46.13 | $48.22 | $50.41 | +0.02% |
| May 30 | $45.30 | $48.23 | $51.36 | +0.05% |
| May 31 | $44.68 | $48.25 | $52.10 | +0.07% |
| Jun 1 | $44.16 | $48.26 | $52.73 | +0.10% |
| Jun 2 | $43.71 | $48.27 | $53.30 | +0.12% |
| Jun 3 | $43.31 | $48.28 | $53.82 | +0.15% |
| Jun 4 | $42.95 | $48.29 | $54.31 | +0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $42.95 | $48.29 | $54.31 | +0.17% |
| Week 2 | $40.98 | $48.38 | $57.11 | +0.35% |
| Week 3 | $39.55 | $48.46 | $59.38 | +0.52% |
| Week 4 | $38.39 | $48.54 | $61.39 | +0.69% |
| Week 5 | $37.41 | $48.63 | $63.22 | +0.87% |
| Week 6 | $36.54 | $48.71 | $64.93 | +1.04% |
| Week 7 | $35.77 | $48.80 | $66.56 | +1.22% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
GeneDx Holdings Corp. is a healthcare company operating in the genomics space that provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
The company also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.
GeneDx was founded in 2000 and is headquartered in Stamford, Connecticut.
GeneDx Holdings Corp. is a healthcare stock currently trading at $47.31 per share, with a market cap of $1.4B and a rank of 2283.
The 30-day price range is $34.93 to $64.08.
Forecasts show a bullish long-term trajectory. The 2026 min/avg/max are $34.51/$47.31/$62.32 with an ROI of 0 and neutral sentiment. From 2027 onward the forecast turns bullish, with 2027 avg $65.76 (ROI 39%), 2028 avg $84.96 (ROI 79.6%), 2029 avg $86.55 (ROI 82.9%), and 2030 avg $99.37 (ROI 110%).
The outlook continues toward 2040 with avg $212.39 (ROI 348.9%) and toward 2050 with avg $391.07 (ROI 726.6%).
A major floor 67.8% below — a decisive break under it would weaken the trend.
The nearest floor, 28.4% below — buyers have tended to step in here.
The nearest ceiling, 44.8% above — a clean break opens room to run.
A major ceiling 124.2% above — clearing it would confirm fresh momentum.
Key WGS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of WGS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $47.40 | Buy | $47.14 | Buy |
| MA 10 | $44.04 | Buy | $46.09 | Buy |
| MA 20 | $46.45 | Buy | $48.30 | Sell |
| MA 50 | $58.40 | Sell | $58.99 | Sell |
| MA 100 | $77.43 | Sell | $74.32 | Sell |
| MA 200 | $104.87 | Sell | $86.59 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 46.08 | Neutral |
| Stoch RSI (14) | 90.06 | Sell |
| CCI (20) | 14.68 | Neutral |
| Williams %R (14) | -11.61 | Info |
| MACD (12,26,9) | 1.63 | Buy |
| ROC (12) | 18.25 | Buy |
| Bollinger %B (20,2) | 0.54 | Neutral |
| Stochastic %K (14) | 88.39 | Sell |
| TRIX (15) | -1.49 | Sell |
| Awesome (5,34) | -7.01 | Sell |
| Ultimate (7,14,28) | 76.88 | Sell |
| Momentum (10) | 8.72 | Buy |
| Aroon Osc (25) | -36.00 | Sell |
| Hull MA (9) | 50.04 | Sell |
| ADX (14) | 21.46 | Sell |
| ATR (14) | 2.43 | Info |
The 30-day technical picture is neutral overall. Sentiment is NEUTRAL, with RSI14 at 40. The 50-day simple moving average (SMA50) is $59.52 and the 200-day simple moving average (SMA200) is $105.44.
Near-term support sits at $34.51 and resistance at $69.83. The 30-day trading range spans from $34.93 to $64.08, indicating a broad near-term price path.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $34.51 | $48.21 | $62.93 | 0% | Neutral | |
| $50.48 | $67.75 | $97.94 | +41% | Bullish | |
| $62.77 | $88.32 | $134.63 | +83% | Bullish | |
| $61.12 | $89.56 | $142.28 | +86% | Bullish | |
| $68.16 | $103.59 | $170.36 | +115% | Bullish | |
| $65.35 | $102.73 | $174.10 | +113% | Bullish | |
| $62.56 | $101.56 | $176.77 | +111% | Bullish | |
| $74.99 | $125.52 | $223.79 | +160% | Bullish | |
| $84.72 | $146.06 | $266.22 | +203% | Bullish | |
| $100.30 | $177.93 | $330.99 | +269% | Bullish | |
| $115.24 | $234.14 | $473.81 | +386% | Bullish | |
| $190.92 | $424.26 | $967.72 | +780% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $34.51 | $48.21 | $57.38 | +0.00% |
| June 2026 | $42.73 | $50.87 | $62.50 | +5.52% |
| July 2026 | $40.85 | $49.31 | $61.89 | -3.07% |
| August 2026 | $38.15 | $46.56 | $59.40 | -5.57% |
| September 2026 | $38.66 | $47.61 | $61.54 | +2.25% |
| October 2026 | $38.99 | $48.42 | $63.34 | +1.71% |
| November 2026 | $37.04 | $46.35 | $61.25 | -4.29% |
| December 2026 | $37.43 | $47.16 | $62.93 | +1.75% |
Click any year to see its month-by-month WGS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, WGS is projected to trade between $34.51 and $62.93, averaging $48.21 — a potential gain of 0% from today's $48.21. Price action looks broadly range-bound.
GeneDx Holdings Corp.'s 2027 outlook centres on $67.75, within a $50.48 to $97.94 range. That is up +41% on the projected 2026 average. That marks a +41% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, WGS could reach as high as $134.63, with a base case around $88.32 and support toward $62.77 — roughly +83% from $48.21. Momentum favours further upside here.
Expect WGS to range from $61.12 to $142.28 through 2029. The $89.56 average target implies a +86% move from current prices. That is up +1% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The WGS price prediction for 2030 points to an average of $103.59 (low $68.16, high $170.36) — a potential gain of +115% on today's $48.21. Momentum favours further upside here.
In 2031, WGS is projected to trade between $65.35 and $174.10, averaging $102.73 — a potential gain of +113% from today's $48.21. That is -1% versus the projected 2030 average. Buyers look set to stay in control over this stretch.
GeneDx Holdings Corp.'s 2032 outlook centres on $101.56, within a $62.56 to $176.77 range. That is -1% versus the projected 2031 average. That marks a +111% change versus current levels. Momentum favours further upside here.
By 2033, WGS could reach as high as $223.79, with a base case around $125.52 and support toward $74.99 — roughly +160% from $48.21. Buyers look set to stay in control over this stretch.
Expect WGS to range from $84.72 to $266.22 through 2034. The $146.06 average target implies a +203% move from current prices. That is up +16% on the projected 2033 average. Momentum favours further upside here.
The WGS price prediction for 2035 points to an average of $177.93 (low $100.30, high $330.99) — a potential gain of +269% on today's $48.21. Buyers look set to stay in control over this stretch.
In 2040, WGS is projected to trade between $115.24 and $473.81, averaging $234.14 — a potential gain of +386% from today's $48.21. That is up +32% on the projected 2035 average. Momentum favours further upside here.
GeneDx Holdings Corp.'s 2050 outlook centres on $424.26, within a $190.92 to $967.72 range. That is up +81% on the projected 2040 average. That marks a +780% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in WGS today (≈ 20.742585 WGS) could be worth
$8,800.19
+$7,800.19 (+780%) by 2050 · US Dollar
Based on the average projected WGS price of $424.26 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in WGSwould be worth at today's price.
$1,000 invested in WGS on May 27, 2025 (≈ 14.287756 WGS) would be worth
$688.81
-$311.19 (-31.1%) today · 0.69× · US Dollar
Based on a WGS entry price of $69.99 vs. today's $48.21.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $44.73 | $1,077.8 | +7.8% |
| 1 month ago | $66.17 | $728.58 | -27.1% |
| 3 months ago | $81.38 | $592.41 | -40.8% |
| 6 months ago | $166.95 | $288.77 | -71.1% |
| 1 year ago | $69.99 | $688.81 | -31.1% |
| All time (5.0y) ago | $420.42 | $114.67 | -88.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our WGS forecast.
Our base-case forecast reaches $96.00 around 2030.
Implied market cap at $96.00: $2.85B
The multi-year forecast shows a steady bullish trajectory with meaningful upside through 2030, 2040, and 2050. The 2030 average is $99.37 with a 110% ROI, the 2040 average is $212.39 with a 348.9% ROI, and the 2050 average is $391.07 with a 726.6% ROI. These figures illustrate a long-term upward path as the asset moves from the near-term price around $47.31 toward higher valuation levels over time.
Sentiment remains bullish across the later forecast years, aligned with rising average prices. These are estimates and not guarantees; actual results can vary with market conditions and company fundamentals.
Tap a question to reveal the answer.
2030 avg $99.37, min $64.56, max $165.30, ROI 110, sentiment BULLISH.
Forecast shows bullish sentiment from 2027 onward, with rising average prices (e.g., 2027 avg $65.76, ROI 39%; 2030 avg $99.37, ROI 110%; 2050 avg $391.07, ROI 726.6). These are estimates, not guarantees.
Yes. The 2034 max is $251.08 and the 2034 avg is $135.85, indicating the potential to exceed $150 within the forecast.
Current price $47.31; Market cap $1.4B.
30-day range is $34.93 to $64.08.
GeneDx Holdings Corp. Community Discussion
0Share your GeneDx Holdings Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.